COVID-19-associated fungal infections
Abstract Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an
important complication in a substantial number of critically ill, hospitalized patients with …
important complication in a substantial number of critically ill, hospitalized patients with …
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
M Hoenigl, D Seidel, A Carvalho… - The Lancet …, 2022 - thelancet.com
Reports of COVID-19-associated mucormycosis have been increasing in frequency since
early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes …
early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes …
Evaluation of serum Mucorales polymerase chain reaction (PCR) for the diagnosis of mucormycoses: the MODIMUCOR prospective trial
L Millon, D Caillot, A Berceanu… - Clinical Infectious …, 2022 - academic.oup.com
Background Early diagnosis and prompt initiation of specific antifungal treatment are
essential for improving the prognosis of mucormycosis. We aimed to assess the …
essential for improving the prognosis of mucormycosis. We aimed to assess the …
Combination of mycological criteria: a better surrogate to identify COVID-19-associated pulmonary aspergillosis patients and evaluate prognosis?
S Dellière, E Dudoignon, S Voicu, M Collet… - Journal of Clinical …, 2022 - Am Soc Microbiol
Diagnosis of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis
(CAPA) remains unclear especially in nonimmunocompromised patients. The aim of this …
(CAPA) remains unclear especially in nonimmunocompromised patients. The aim of this …
Microbiological and molecular diagnosis of mucormycosis: from old to new
N Lackner, W Posch, C Lass-Flörl - Microorganisms, 2021 - mdpi.com
Members of the order Mucorales may cause severe invasive fungal infections
(mucormycosis) in immune-compromised and otherwise ill patients. Diagnosis of Mucorales …
(mucormycosis) in immune-compromised and otherwise ill patients. Diagnosis of Mucorales …
Recognition of diagnostic gaps for laboratory diagnosis of fungal diseases: expert opinion from the Fungal Diagnostics Laboratories Consortium (FDLC)
Fungal infections are a rising threat to our immunocompromised patient population, as well
as other nonimmunocompromised patients with various medical conditions. However, little …
as other nonimmunocompromised patients with various medical conditions. However, little …
An update on current and novel molecular diagnostics for the diagnosis of invasive fungal infections
Background Invasive fungal infections cause millions of infections annually, but diagnosis
remains challenging. There is an increased need for low-cost, easy to use, highly sensitive …
remains challenging. There is an increased need for low-cost, easy to use, highly sensitive …
Epidemiology, modern diagnostics, and the management of mucorales infections
D Pham, AR Howard-Jones, R Sparks, M Stefani… - Journal of Fungi, 2023 - mdpi.com
Mucormycosis is an uncommon, yet deadly invasive fungal infection caused by the
Mucorales moulds. These pathogens are a WHO-assigned high-priority pathogen group, as …
Mucorales moulds. These pathogens are a WHO-assigned high-priority pathogen group, as …
Liposomal amphotericin B—the present
Most invasive fungal infections are opportunistic in nature but the epidemiology is constantly
changing, with new risk groups being identified. Neutropenia is a classical risk factor for …
changing, with new risk groups being identified. Neutropenia is a classical risk factor for …
Emerging diagnostics and therapeutics for invasive fungal infections
DZP Friedman, IS Schwartz - Infectious Disease Clinics, 2023 - id.theclinics.com
The number of patients at risk for fungal infections continues to increase because of
improved survival of medically and surgically complex patients, new indications for …
improved survival of medically and surgically complex patients, new indications for …